Varsetatug Biosimilar – Research Grade from ProteoGenix; catalogue PX-TA2520; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Varsetatug Biosimilar – Research Grade is a humanized monoclonal antibody designed for research involving epithelial cell adhesion molecule, also known as EpCAM, TROP1, or CD326. EpCAM is widely studied as a tumor-associated research target because of its expression in epithelial-derived cancers and its role in cell adhesion, proliferation, migration, and tumor biology.
This research-grade biosimilar is intended to help scientists investigate EpCAM-mediated mechanisms and evaluate antibody-based targeting strategies in controlled experimental workflows.
Varsetatug binds EpCAM, a transmembrane glycoprotein involved in epithelial cell behavior and cancer-associated signaling. By recognizing this surface antigen, Varsetatug Biosimilar – Research Grade can be used to study EpCAM-positive cell populations, receptor engagement, antibody binding profiles, and downstream effects linked to tumor cell biology.
Its specificity for EpCAM makes it relevant for oncology research focused on epithelial tumors and antibody-based approaches to cancer target validation.
Varsetatug Biosimilar – Research Grade is suitable for studies involving EpCAM expression analysis, tumor antigen validation, antibody screening, binding characterization, and comparative biosimilar evaluation. It may support research in colorectal, breast, prostate, ovarian, and other epithelial cancer models where EpCAM is investigated as a therapeutic or diagnostic research target.
This product can also be used in workflows assessing antibody-antigen interaction, cell-surface marker recognition, and the development of EpCAM-focused experimental assays.
Researchers may use Varsetatug Biosimilar – Research Grade in flow cytometry, binding assays, cell-based functional studies, immunoassay development, and EpCAM-positive cancer cell model characterization. It is also relevant for comparing antibody performance, validating EpCAM expression across cell lines, and supporting early-stage studies of antibody-guided targeting strategies.
Its research-grade format makes it a practical choice for laboratories looking for a reliable Varsetatug biosimilar reagent for exploratory oncology research and assay development.
Varsetatug Biosimilar – Research Grade is supplied for research use only. It is not intended for diagnostic, therapeutic, or clinical applications.
ProteoGenix catalogue number PX-TA2520.
Target: Varsetatug Biosimilar – Research Grade; Host: Mammalian cells; Clonality: Monoclonal antibody; Expression system: Mammalian; Purity: >95% as determined by SDS-PAGE; Buffer: 0.01 M PBS pH 7.4.
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
